Decheng Capital Global Life Sciences Fund IV, L.P. 13D and 13G filings for Equillium, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 5:21 pm Purchase |
2021-02-05 | 13D | Equillium, Inc. EQ |
Decheng Capital Global Life Sciences Fund IV, L.P. | 5,733,021 19.700% |
5,733,021 (New Position) |
Filing |